Overview

A Study to Evaluate the Efficacy and Safety of ANB019 in the Treatment of Subjects With Ichthyosis

Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
0
Participant gender:
All
Summary
Efficacy and Safety of ANB019 in Subjects with Ichthyosis
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AnaptysBio, Inc.
Criteria
Inclusion Criteria:

- Diagnosis of Ichthyosis

- IASI total score ≥ 18, erythema score ≥ 2

- Subject has been using emollient daily for at least 1 week prior to Day 1 and agrees
to continue using that same emollient daily at the same frequency throughout the study

Exclusion Criteria:

- A subject with ichthyosis vulgaris, X-linked ichthyosis, or lamellar ichthyosis will
be excluded.